Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) has provided an update.
EZZ Life Science Holdings Ltd. has announced its Annual General Meeting to be held on November 28, 2025. Key agenda items include the consideration of financial statements, the adoption of the remuneration report, the re-election of director Glenn Cross, and the approval of a mandate to issue equity securities. These resolutions are significant as they impact the company’s governance and capital structure, potentially influencing shareholder value and strategic direction.
The most recent analyst rating on (AU:EZZ) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Ltd. operates in the life sciences industry, focusing on the development and distribution of health and wellness products. The company is known for its innovative solutions in biotechnology and consumer health, catering to a diverse market that includes both local and international stakeholders.
Average Trading Volume: 86,094
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$151M
See more data about EZZ stock on TipRanks’ Stock Analysis page.